Physician
Internal Medicine
Dr. Carl R. Alving, MD
|
|
Give Review
Carl R. Alving, MD works in the field of Internal Medicine. He researched medicine at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine Carl R. Alving, MD is also published. He has 101 publications published. The lastest publication: "Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1.'
Publications
- Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.
- Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.
- Adjuvants for vaccines to drugs of abuse and addiction.
- Designing the epitope flanking regions for optimal generation of CTL epitopes.
- Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine,...
- HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development.
- Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs.
- Designing a soluble near full-length HIV-1 gp41 trimer.
- HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses.
- Adjuvants for human vaccines.
- Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.
- Anthrax Vaccine Antigen-Adjuvant Formulations Completely Protect New Zealand White Rabbits against Challenge with Bacillus anthracis Ames Strain Spores.
- Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A b...
- Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.
- Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.
- Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.
- The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.
- The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.
- Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines.
- Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.
- Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.
- Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
- Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
- Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.
- Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
- Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
- Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.
- Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.
- In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-lengt...
- Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcu...
- Antibodies to lipids and liposomes: immunology and safety.
- Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigs.
- Needle-free skin patch vaccination method for anthrax.
- Immunization with DNA through the skin.
- Complement activation during hemorrhagic shock and resuscitation in swine.
- F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
- Trafficking of liposomal antigens to the trans-Golgi complex in macrophages.
- Oil-in-water liposomal emulsions for vaccine delivery.
- The interaction of liposomes with the complement system: in vitro and in vivo assays.
- Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(...
- Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.
- Isolation and purification of proteasomes from primary cells.
- Platelets and Erythrocyte-Bound Platelets Bind Infectious HIV-1 in Plasma of Chronically Infected Patients.
- Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1.
- Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.
- Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
- Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes.
- Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation.
- Antibodies to cholesterol: biological implications of antibodies to lipids.
- Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.
- Gangliosides elicit a T-cell independent antibody response.
- ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.
- Novel adjuvant strategies for experimental malaria and AIDS vaccines.
- Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
- Complement-dependent phagocytosis of liposomes.
- Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
- A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
- Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
- Liposomes as carriers for vaccines.
- Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen.
- Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
- Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity.
- Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
- Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.
- Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.
- Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination.
- Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen.
- Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.
- Anti-liposome antibodies induced by lipid A. I. Influence of ceramide, glycosphingolipids, and phosphocholine on complement damage.
- Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.
- Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits.
- Liposomes as vehicles for vaccines.
- Antibodies against liposomes in normal and immune-defective mice.
- Binding of diphtheria toxin to phospholipids in liposomes.
- Membrane lipid composition modulates the binding specificity of a monoclonal antibody against liposomes.
- Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.
- Selective cytotoxicity of tumor cells induced by liposomes containing plant phosphatidylinositol.
- Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes.
- Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
- Natural antibodies against phospholipids and liposomes in humans.
- Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.
- Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement.
- Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.
- Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin.
- Antibodies to lipid A: occurrence in humans.
- Mitogenic response of lymphocytes from C3H/HeJ mice in the presence of lipid A and lipid A fractions.
- Heterogeneity of lipid A.
- Heterogeneity of lipid A: comparison of lipid A types from different gram-negative bacteria.
- Lipid A fractions analyzed by a technique involving thin-layer chromatography and enzyme-linked immunosorbent assay.
- Delivery of liposome-encapsulated drugs to macrophages.
- The malaria merozoite surface: a 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites.
- Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes.
- Mitogenic activities of lipid A and liposome-associated lipid A: effects of epitope density.
- Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits.
- Influence of temperature on complement-dependent immune damage to liposomes.
- Localization of urinary lactosylceramide in cytoplasmic vesicles of renal tubular cells in homozygous familial hypercholesterolemia.
- Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes.
- Antibody binding and complement fixation by a liposomal model membrane.
- A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.
- Liposomal adjuvants for human vaccines.
Schools
University of Miami School of Medicine
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Washington University - Barnes-Jewish Hospital -
University of Miami Miller School of Medicine
Helpful Reviews
Similar Doctors
|
|
Lewellys F. Barker
 This Doctor is OpenDoctor Recommended.
|
|
|
Roberto Prizont
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan A. Leggett-Johnson, MD |
|
|
Dr. Juan C. Baez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira Y. Rabin, MD |
|
|
Dr. Danilo G. Molieri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred Muller, MD |
|
|
Dr. Ihuoma G. Emenuga, MD |
|
|
Dr. Swaroop G. Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osamuyimen O. Igbinosa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy P. Patterson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcia P. Goldmark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher C. Dunford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Passi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Petek Donmez, MD
This Doctor is OpenDoctor Recommended.
|